Piramal Pharma

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue2,1092,1832,7982,3592,653
Expenses2,1702,2462,5932,3862,589
EBITDA224.29238.97506.57284.61384.67
EBIT36.24-4.62125.9980.62169.26
Profit Before Tax-46.18-93.8643.00-7.4681.63
Net Profit-99.22-136.19-8.83-69.395.03
Financial Ratios
Operating Profit Margin11.70%9.73%12.51%13.40%15.38%
Net Profit Margin-4.85%-5.40%4.18%-3.06%0.21%
Earning Per Share (Diluted)-0.75-1.03-0.07-0.520.04
Dividends Per Share0.000.000.000.000.00